Kazuhiro Oohara

Title: **Kazuhiro Oohara: Innovator in Human Serum Albumin Production**

Introduction

Kazuhiro Oohara, an inventive mind located in Osaka, Japan, has made significant strides in biotechnology through his work in recombinant human serum albumin. With a total of three patents to his name, his innovations are pivotal in the field of pharmaceuticals, addressing the critical need for purified human serum albumin.

Latest Patents

Oohara's latest patent focuses on a sophisticated process for producing recombinant human serum albumin. This method employs a multi-step purification process that includes ultrafiltration, heat treatment, and acid treatment, among others. The process ensures that the final human serum albumin product is free from proteinous and polysaccharide contaminants. Furthermore, the resulting substance can be used in pharmaceutical formulations, marking a significant advancement in the purity and efficiency of recombinant proteins.

Career Highlights

Kazuhiro Oohara's career at The Green Cross Corporation has been characterized by his commitment to innovation in biopharmaceutical production. His work has contributed not only to the scientific community but also to improvements in therapeutic applications for patients requiring human serum albumin.

Collaborations

Throughout his career, Oohara has worked alongside esteemed colleagues such as Takao Ohmura and Akinori Sumi. Their collaborative efforts have undoubtedly enhanced the research and development framework within which Oohara operates, enabling the successful realization of complex biotechnological processes.

Conclusion

In summary, Kazuhiro Oohara stands out as a remarkable inventor whose contributions to the efficient purification of recombinant human serum albumin are noteworthy. His patents reflect a deep understanding of biotechnology and a dedication to enhancing pharmaceutical products, making significant impacts in healthcare.